MIAMI — Attorneys for the state of Florida argued before a federal appeals court Wednesday that a lower-court judge was wrong to block a law last year that bans gender-affirming care for minors and restricts similar care for adults, though a pending U.S. Supreme Court case creates uncertainty.
Attorneys presented oral arguments before the 11th U.S. Circuit Court of Appeals in Miami. Meanwhile, the Supreme Court is already reviewing a similar ban in Tennessee, and the conservative court's ruling could affect laws in about two dozen other states.
Florida's law, which is still in effect, prohibits transgender minors from being prescribed puberty blockers and hormonal treatments, even with their parents' permission. It also requires that transgender adults only receive treatment from a doctor and not from a registered nurse or other qualified medical practitioner. Adults who want the treatment must be in the room with the physician when signing the consent form.
U.S. District Judge Robert Hinkle had blocked the law in June, but a three-judge panel last fall stayed the lower court order against the ban while the matter is appealed, meaning the ban is currently being enforced.
For minors, the only treatments at issue are puberty blocking treatments and cross-sex hormones — giving testosterone to someone assigned female at birth, for example. Those who were undergoing treatment when the law was adopted in May 2023 were allowed to continue. Surgery, which is rare for minors, was still blocked.
As part of the state's appeal, attorney Mohammad Jazil told a three-judge appeals panel on Wednesday that Hinkle was wrong to conclude that the law was based on hostility from state officials and lawmakers against transgender people, rather than sound medical science.
''The district court itself recognizes that there are concerns with this treatment, that guardrails are appropriate, stringent regulation is appropriate," Jazil said.
The district judge was wrong to prioritize the views of a few lawmakers over the meritorious reasons to regulate treatment, Jazil said.